| Donation after circulatory death today: an updated overview of the European landscape M Lomero, D Gardiner, E Coll, B Haase‐Kromwijk, F Procaccio, F Immer, ... Transplant International 33 (1), 76-88, 2020 | 186 | 2020 |
| Olaparib as maintenance therapy in patients with BRCA 1–2 mutated recurrent platinum sensitive ovarian cancer: real world data and post progression outcome SC Cecere, G Giannone, V Salutari, L Arenare, D Lorusso, G Ronzino, ... Gynecologic Oncology 156 (1), 38-44, 2020 | 81 | 2020 |
| SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand R Palmirotta, C Carella, E Silvestris, M Cives, SL Stucci, M Tucci, ... Oncotarget 9 (38), 25355, 2018 | 43 | 2018 |
| Standardization of CTC AR‐V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression S Tommasi, B Pilato, C Carella, A Lasorella, K Danza, I Vallini, ... The Prostate 79 (1), 54-61, 2019 | 23 | 2019 |
| Randomized phase II study of niraparib plus best supportive care (BSC) versus BSC alone as maintenance treatment in patients with advanced urothelial carcinoma (UC) whose … F Vignani, R Tambaro, U De Giorgi, P Giannatempo, D Bimbatti, C Carella, ... Journal of Clinical Oncology 40 (6_suppl), 442-442, 2022 | 13 | 2022 |
| Local treatment with deep percutaneous electrochemotherapy of different tumor lesions: Pain relief and objective response results from an observational study G Ranieri, C Laface, V Fazio, D De Ceglia, F Macina, V Gisone, M Porcelli, ... Eur. Rev. Med. Pharmacol. Sci 24, 7764-7775, 2020 | 10 | 2020 |
| Council of Europe black sea area project: international cooperation for the development of activities related to donation and transplantation of organs in the region E Arredondo, M López-Fraga, E Chatzixiros, B Senemaud, P Brezovsky, ... Transplantation proceedings 50 (2), 374-381, 2018 | 9 | 2018 |
| Vigilance for medical products of human origin—progress on the notify Library’s global effort to share information and learning E Petrisli, C Carella, A Navarro, D Fehily, DM Strong, M Cardillo Transplantation 105 (9), 1921-1929, 2021 | 7 | 2021 |
| First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin R Iacovelli, C Ciccarese, M Brunelli, N Battelli, C Buttigliero, C Caserta, ... Annals of Oncology 33 (11), 1179-1185, 2022 | 6 | 2022 |
| The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma … SE Rebuzzi, A Signori, M Stellato, D Santini, M Maruzzo, U De Giorgi, ... Frontiers in Oncology 12, 955501, 2022 | 6 | 2022 |
| Addition of niraparib to best supportive care as maintenance treatment in patients with advanced urothelial carcinoma whose disease did not progress after first-line platinum … F Vignani, R Tambaro, U De Giorgi, P Giannatempo, D Bimbatti, C Carella, ... European Urology 83 (1), 82-89, 2023 | 5 | 2023 |
| Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study SC Cecere, L Musacchio, M Bartoletti, V Salutari, L Arenare, D Lorusso, ... International Journal of Gynecologic Cancer 31 (7), 2021 | 5 | 2021 |
| Characterization of a Rare Nonpathogenic Sequence Variant (c.1905C>T) of the Dihydropyrimidine Dehydrogenase Gene (DPYD) R Palmirotta, D Lovero, E Silvestris, C Carella, C Felici, D Quaresmini, ... The International journal of biological markers 32 (3), 357-360, 2017 | 5 | 2017 |
| Analysis of the organ offers received from European Union countries before and after the introduction of a dedicated information technology portal: the COORENOR/FOEDUS portal D Peritore, L Rizzato, P Di Ciaccio, S Trapani, C Carella, A Oliveti, ... Transplantation Proceedings 49 (4), 629-631, 2017 | 5 | 2017 |
| Pembrolizumab plus axitinib for metastatic papillary and chromophobe renal cell carcinoma: NEMESIA (non clear MEtaStatic renal cell carcinoma pembrolizumab axitinib) study, a … M Stellato, S Buti, M Maruzzo, M Bersanelli, F Pierantoni, U De Giorgi, ... International Journal of Molecular Sciences 24 (2), 1096, 2023 | 4 | 2023 |
| Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study G Roviello, E Gambale, R Giorgione, D Santini, M Stellato, G Fornarini, ... Cancer Medicine 11 (16), 3084-3092, 2022 | 4 | 2022 |
| Cross Border Organ Exchange Among EU Members States. Preliminary Results of the Foedus-EOEO it Portal C Carella, P Di Ciaccio, M Adamec, K Laouabdia, O Huot, I Martínez, ... Transplantation 101, S90, 2017 | 4 | 2017 |
| Ki67 as a predictor of response to PARP inhibitors in platinum sensitive BRCA wild type ovarian cancer: the MITO 37 retrospective study V Tuninetti, E Ghisoni, S Pignata, E Picardo, F Raspagliesi, C Andreetta, ... Cancers 15 (4), 1032, 2023 | 3* | 2023 |
| Compassionate use program of ipilimumab and nivolumab in intermediate or poor risk metastatic renal cell carcinoma: a large multicenter Italian study U Basso, F Paolieri, M Rizzo, U De Giorgi, S Bracarda, L Antonuzzo, ... Cancers 14 (9), 2293, 2022 | 3 | 2022 |
| Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy L Lombardini, A Bosi, S Grosz, D Pamphilon, D Fehily, M Mareri, ... Vox Sanguinis 105 (2), 174-176, 2013 | 3 | 2013 |
